WHWK files Form 144 to sell 366,532 RSUs
Whitehawk Therapeutics (WHWK) filed a Form 144 reporting an intended sale of 366,532 Restricted Stock Units with an applicable date of 04/01/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Whitehawk Therapeutics (WHWK) filed a Form 144 reporting an intended sale of 366,532 Restricted Stock Units with an applicable date of 04/01/2026. The filing shows 1,834 shares of Common Stock were sold on 03/02/2026 for $6,069.80.
Key Figures
Key Terms
Restricted Stock Units financial
Form 144 regulatory
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does WHWK's Form 144 report about the planned sale?
Which broker and market are listed on the WHWK Form 144?
Are the planned sales in WHWK's Form 144 listed as issuer or holder transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.